R&D channel feed – Endpoints News

R&D channel feed

Viking's oral weight loss drug appears to have strong effect in Phase 1 trial

6 months ago

CinRx touts positive early-stage data from two obesity candidates

6 months ago

Novo Nordisk claims late-stage MASH victory, continuing GLP-1's expansion

6 months ago

Essa’s shares tank as it looks for options after abandoning prostate cancer drug

6 months ago

UCB's anti-tau Alzheimer's program fails Phase 2 primary endpoint, but highlights positive secondaries

6 months ago

‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar

6 months ago

Takeda says multiyear restructuring is 'on track'

6 months ago

Amgen makes pipeline cuts, but obesity plans remain the focus

6 months ago

Corcept misses primary endpoint in supportive Cushing's syndrome study

6 months ago

Compass Pathways delays key Phase 3 psilocybin readouts, spurring 30% layoffs

6 months ago

Lexeo shares early data on Alzheimer’s gene therapy

6 months ago

Roche presents early-stage results for latest amyloid-based Alzheimer's attempt

6 months ago

Atlas of tumors reveals in 3D how cells change into cancer

6 months ago

Hints of impatience grow with Biogen as it tries to find a bridge to growth

6 months ago

GSK cuts 24-valent pneumococcal program for adults due to competition

6 months ago

Biogen signs molecular glue deal, raises yearly projections

6 months ago

Sage, Biogen won't pursue major depression approval for postpartum pill

6 months ago

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

6 months ago

Coya shares sink on Phase 2 Alzheimer's data for deprioritized drug

6 months ago

Shionogi touts topline data for Covid-19 antiviral for post-exposure treatment

6 months ago

PacBio bets on 'inflection point' with $500 long-read genome

6 months ago

In bid to lower ARIA-E, Eli Lilly tries a different dosing regimen for its Alzheimer's drug

6 months ago

Two type 1 diabetes patients are insulin-free after Eledon's immunosuppressant and an islet transplant

6 months ago

Eyepoint sells $100M in shares after unveiling eye disease data for drug-device asset

6 months ago

First page Previous page 18 19 202122 23 24 Next page Last page